The results for ANGPTL4 are not statistically significant after correction for multiple testing but it can be seen that they are consistent with the possibility that LOF variants lower hyperlipidaemia risk modestly, with OR 0.78 and SLP −1.84. Here, ANGPTL4 is linked to hyperlipidemia.